Global Acute Myeloid Leukemia Therapeutics Market 2015-2019

TechNavio Insights

USA – CANADA – UK – CHINA – INDIA

Market Overview: Acute Myeloid LeukemiaTherapeuticsAbout Acute Myeloid Leukemia Therapeutics

• Acute myeloid leukemia, also known as acute myelogenous leukemia, is a group of clonal hematopoietic disorders caused by the malignancy of hematopoietic stem cells or lineage-specific progenitor cells.

• Neoplasms undergo proliferation in the bone marrow and, in later stages, spread rapidly throughout the different parts of the body such as the spleen, lymph node, liver, brain, spinal cord, and testicles via the blood.

• In most of the cases, acute myeloid leukemia originates in cells that would develop into WBCs (other than lymphocytes); however, in certain cases, it can originate in other blood-forming cells of the body.

• The main characteristic of acute myeloid leukemia is the clonal expansion of the myeloblasts, resulting in suppression of normal hematopoiesis.

• Some of the clinical symptoms of acute myeloid leukemia are fever, pallor, fatigue, and hemorrhages.

• Exposure to certain chemicals such as benzene, exposure to radiation, exposure to chemotherapy by cancer patients, blood disorders, genetic mutations, and smoking are some of the risk factors leading to the development of acute myeloid leukemia in patients.

• The Global Acute Myeloid Leukemia Therapeutics market is expected to grow at a very rapid pace posting a CAGR of 19.75 percent during the period 2014-2019.

USA – CANADA – UK – CHINA – INDIA

Covered in This Report

• This report covers the present scenario and the growth prospects of the Global Acute Myeloid Leukemia Therapeutics market for the period 2015-2019.

• To calculate the market size, the report considers the revenue generated from the sales of various generic, off-label, and branded drugs used in the treatment of acute myeloid leukemia.

• The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Acute Myeloid Leukemia Therapeutics market.

• In addition, the report discusses the major drivers that influence the growth of the market.

• It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

USA – CANADA – UK – CHINA – INDIA

Key Regions

Americas

APAC

EMEA

USA – CANADA – UK – CHINA – INDIA

Key Vendors

Key Vendors• Bristol-Myers Squibb Co.• Celgene Corp.• Johnson & Johnson• Pfizer Inc

Other Prominent Vendors• Abbott• Ambit BioSciences• Amgen• Astex Pharmaceuticals• AstraZeneca• Baxter Healthcare• Bayer• Boehringer Ingelheim• Celator Pharmaceuticals• CTI Biopharma (formerly, Cell Therapeutics)• Chroma Therapeutics• Chugai Pharmaceutical• Cyclacel Pharmaceuticals

USA – CANADA – UK – CHINA – INDIA

Market Drivers, Challenges and Trends

Guest Bloggers

A detailed analysis of each market driver, challenge and trend is

available in our report:

Global Acute Myeloid Leukemia

Therapeutics Market 2015-2019

Driver• Presence of High Unmet Needs.• For a full, detailed list, view our report.

Challenge• High Cost of Treatment .• For a full, detailed list, view our report.

Trend• Expected Entry of Novel Drugs .• For a full, detailed list, view our report.

USA – CANADA – UK – CHINA – INDIA

Key Questions

Questions Answered in Our Report

• What will the market size be in 2018 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key

vendors?• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

USA – CANADA – UK – CHINA – INDIA

View Our Report

Global Acute Myeloid Leukemia Therapeutics Market 2015-2019

View Report >>

TechNavio's report, Global Acute Myeloid Leukemia Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Published on: December 24, 2014 | 84 Pages | SKU: IRTNTR4899

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501  

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

Mail us at: enquiry@technavio.com

You can visit us at:www.technavio.com

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of

or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION